Your browser doesn't support javascript.
loading
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
Peters, Marion G; Yuen, Man-Fung; Terrault, Norah; Fry, John; Lampertico, Pietro; Gane, Ed; Hwang, Carey; Stamm, Luisa M; Leus, Mitchell; Maini, Mala K; Mendez, Patricia; Lonjon-Domanec, Isabelle; Berg, Thomas; Wang, Su; Mishra, Poonam; Donaldson, Eric; Buchholz, Stephanie; Miller, Veronica; Lenz, Oliver.
Afiliação
  • Peters MG; Department of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Yuen MF; Department of Medicine, School of Clinical Medicine & State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, China.
  • Terrault N; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Fry J; Aligos Therapeutics, Clinical Development Consultant, San Francisco, California, USA.
  • Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Gane E; Department of Pathophysiology and Transplantation, CRC "A. M. and A. Migliavacca" Center for Liver Disease, University of Milan, Milan, Italy.
  • Hwang C; Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Stamm LM; Vir Biotechnology, San Francisco, California, USA.
  • Leus M; Assembly Biosciences, South San Francisco, California, USA.
  • Maini MK; Forum for Collaborative Research, University of California, Berkeley School of Public Health, Washington, DC, USA.
  • Mendez P; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Lonjon-Domanec I; Gilead Sciences, Warren, New Jersey, USA.
  • Berg T; Janssen Pharmaceutica, Issy les Moulineaux, France.
  • Wang S; Department of Medicine, Leipzig University Medical Center, Leipzig, Germany.
  • Mishra P; Cooperman Barnabas Medical Center, RWJBarnabas-Rutgers Medical Group, Livingston, New Jersey, USA.
  • Donaldson E; Division of Antivirals, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Buchholz S; Division of Antivirals, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Miller V; Department 32 Infectiology, Dermatology and Allergology, Federal Institute for Drugs and Medical Devices, Germany.
  • Lenz O; Forum for Collaborative Research, University of California, Berkeley School of Public Health, Washington, DC, USA.
Clin Infect Dis ; 78(4): 983-990, 2024 Apr 10.
Article em En | MEDLINE | ID: mdl-37633256

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Hepatite B Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos